Erratum: AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137 [Med. Phys. 36, 5310‐5322, 2009]

We would like to update the Table 1 in the aforementioned report1 by the following:

Table 1.

Examples of radiobiological indices for uniform dose distributions. (Calculated with: α = 0.15 Gy⁻¹, β = 0.05 Gy⁻², α/β = 3.0 Gy, T _p = 42 days, repair half‐life of 0.27 h, N ₀ = 1 × 10⁶, and radioactive decay half‐life of 59.4, 16.991, and 9.7 days for ¹²⁵I, ¹⁰³Pd, and ¹³¹Cs, respectively)

Indices	Radionuclide
	125I	103Pd	131Cs
Dose (Gy)	145.0	125.0	120.0
BED (Gy)	111.1	115.4	117.3
TCP (%)	94.4	97.0	97.7
Teff (day)	234.2	94.0	61.0

This update corrects a variable referencing error in the Excel spreadsheet used in the numerical calculation of cumulative dose at effective treatment time which also affected the BED and TCP values listed in the table. In addition, the values of radioactive decay half‐life used in numerical calculation are now included to facility easy comparison by readers in the future.

We thank Nelson Miksys, Mehan Haidari, and Rowan Thomson, Ph.D. for bringing to our attention their effort in reproducing the results of original Table 1 which led to this update.